期刊
BIOMOLECULES
卷 13, 期 6, 页码 -出版社
MDPI
DOI: 10.3390/biom13060947
关键词
bacterial spores; spore display system technology; mucosal vaccine; spore engineering; Bacillus subtilis
Mucosal vaccines have advantages such as inducing adaptive immunity and needle-less vaccinations, but their development is currently limited. Innovative antigens, efficient adjuvants, and delivery systems are crucial for effective mucosal vaccines. Bacterial spores have shown promise as antigen vehicles due to their unique structure and ability to induce protective immune responses when mucosally administered.
Mucosal vaccines offer several advantages over injectable conventional vaccines, such as the induction of adaptive immunity, with secretory IgA production at the entry site of most pathogens, and needle-less vaccinations. Despite their potential, only a few mucosal vaccines are currently used. Developing new effective mucosal vaccines strongly relies on identifying innovative antigens, efficient adjuvants, and delivery systems. Several approaches based on phages, bacteria, or nanoparticles have been proposed to deliver antigens to mucosal surfaces. Bacterial spores have also been considered antigen vehicles, and various antigens have been successfully exposed on their surface. Due to their peculiar structure, spores conjugate the advantages of live microorganisms with synthetic nanoparticles. When mucosally administered, spores expressing antigens have been shown to induce antigen-specific, protective immune responses. This review accounts for recent progress in the formulation of spore-based mucosal vaccines, describing a spore's structure, specifically the spore surface, and the diverse approaches developed to improve its efficiency as a vehicle for heterologous antigen presentation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据